» Articles » PMID: 22152027

Genetic Variants in IFIH1 Play Opposite Roles in the Pathogenesis of Psoriasis and Chronic Periodontitis

Overview
Date 2011 Dec 14
PMID 22152027
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The IFIH1 gene is a key factor connecting environmental and genetic factors in the pathogenesis of immune-related diseases. We aimed to investigate whether it has effects on psoriasis, chronic periodontitis and skin test-positive penicillin allergy and to confirm whether these diseases have shared molecular mechanisms originating from shared genetics. Two common variants in IFIH1 were genotyped in 561 patients with psoriasis, 421 patients with chronic periodontitis, 175 patients with skin test-positive penicillin allergy and 1100 shared controls. Then, case-control study was used to analyse the association between IFIH1 and the three diseases. The allele distributions of rs1990760 and rs3747517 in the Chinese population are much different from the European population. The A allele of rs1990760 (OR = 1.30, P = 5.4 × 10(-3)) and A-G (rs1990760/rs3747517) haplotype (OR = 1.31, P = 3.8 × 10(-3)) were highly associated with the risk of psoriasis. However, the A allele of rs1990760 (OR = 0.73, P = 7.8 × 10(-3)) and A-G haplotype (OR = 0.71, P = 4.5 × 10(-3)) were identified as protective factors for chronic periodontitis. IFIH1 affects several immune-related diseases, including psoriasis and chronic periodontitis, and provides a molecular link between genetic susceptibility, viral infections and immune-related diseases. Moreover, we also confirm the hypothesis that shared molecular mechanisms from common genetic variants contribute to a spectrum of immune-related diseases.

Citing Articles

Novel genetic insight for psoriasis: integrative genome-wide analyses in 863 080 individuals and proteome-wide Mendelian randomization.

Liu S, Li L, Liang Y, Tan Y, Wang X, Feng Y Brief Bioinform. 2025; 26(1).

PMID: 39883516 PMC: 11781221. DOI: 10.1093/bib/bbaf032.


Heterozygous de novo dominant negative mutation of REXO2 results in interferonopathy.

Idiiatullina E, Al-Azab M, Lin M, Hrovat-Schaale K, Liu Z, Li X Nat Commun. 2024; 15(1):6685.

PMID: 39107301 PMC: 11303720. DOI: 10.1038/s41467-024-50878-w.


Genetic association of beta-lactams-induced hypersensitivity reactions: A systematic review of genome-wide evidence and meta-analysis of candidate genes.

Lumkul L, Wongyikul P, Kulalert P, Sompornrattanaphan M, Lao-Araya M, Chuamanochan M World Allergy Organ J. 2023; 16(9):100816.

PMID: 37780578 PMC: 10541471. DOI: 10.1016/j.waojou.2023.100816.


Cognitive Process of Psoriasis and Its Comorbidities: From Epidemiology to Genetics.

Gao J, Shen X, Ko R, Huang C, Shen C Front Genet. 2021; 12:735124.

PMID: 34899832 PMC: 8662384. DOI: 10.3389/fgene.2021.735124.


Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers.

Bucalo A, Rega F, Zangrilli A, Silvestri V, Valentini V, Scafetta G Int J Mol Sci. 2020; 21(21).

PMID: 33114187 PMC: 7660646. DOI: 10.3390/ijms21217873.